blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0802188

EP0802188 - Phenylglycinolamides linked by a hetero-atom with antiatherosclerotic agents [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  30.11.2001
Database last updated on 15.06.2024
Most recent event   Tooltip30.11.2001No opposition filed within time limitpublished on 16.01.2002  [2002/03]
Applicant(s)For all designated states
BAYER AG
51368 Leverkusen / DE
[1997/43]
Inventor(s)01 / Goldmann, Siegfried, Dr.
Am Osterholz 91
42327 Wuppertal / DE
02 / Müller, Ulrich, Dr.
Neuer Triebel 91
42111 Wuppertal / DE
03 / Connell, Richard, Dr.
68 Lobsterback Road
Trumbull, CT 06611 / US
04 / Bischoff, Hilmar, Dr.
Am Rohm 78
42113 Wuppertal / DE
05 / Denzer, Dirk, Dr.
Claudiusweg 7
42115 Wuppertal / DE
06 / Grützmann, Rudi, Dr.
Helsinkistrasse 20
42657 Solingen / DE
07 / Beuck, Martin, Dr.
Trills 7
40699 Erkrath / DE
[1997/43]
Application number, filing date97105705.407.04.1997
[1997/43]
Priority number, dateDE199611526218.04.1996         Original published format: DE 19615262
[1997/43]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report 
No.:EP0802188
Date:22.10.1997
Language:DE
[1997/43]
Type: B1 Patent specification 
No.:EP0802188
Date:24.01.2001
Language:DE
[2001/04]
Search report(s)(Supplementary) European search report - dispatched on:EP04.09.1997
ClassificationIPC:C07D213/74, C07D213/70, C07D213/75, C07C233/22, C07D233/84, C07D215/36, C07D235/28, C07D239/95, A61K31/44, A61K31/41, A61K31/47, A61K31/165
[1997/43]
CPC:
C07D213/70 (EP,US); A61P9/00 (EP); A61P9/10 (EP);
C07C237/20 (EP,US); C07C237/22 (EP,US); C07C323/60 (EP,US);
C07C323/62 (EP,US); C07C333/04 (EP,US); C07D213/74 (EP,US);
C07D213/75 (EP,US); C07D215/12 (EP,US); C07D215/227 (EP,US);
C07D215/36 (EP,US); C07D215/48 (EP,US); C07D233/84 (EP,US);
C07D235/28 (EP,US); C07D239/95 (EP,US); C07C2601/08 (EP,US);
C07C2601/18 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1997/43]
TitleGerman:Heteroverknüpfte Phenylglycinolamide als antitherosklerotische Arzneimittel[1997/43]
English:Phenylglycinolamides linked by a hetero-atom with antiatherosclerotic agents[1997/43]
French:Phénylglycinolamides reliées par un hétéro-atome ayant une activité antithérosclérotique[1997/43]
Examination procedure22.04.1998Examination requested  [1998/25]
14.01.1999Despatch of a communication from the examining division (Time limit: M04)
20.05.1999Reply to a communication from the examining division
05.11.1999Despatch of communication of intention to grant (Approval: No)
11.05.2000Despatch of communication of intention to grant (Approval: later approval)
27.07.2000Communication of intention to grant the patent
06.11.2000Fee for grant paid
06.11.2000Fee for publishing/printing paid
Divisional application(s)EP00109077.8  / EP1028112
Opposition(s)25.10.2001No opposition filed within time limit [2002/03]
Fees paidRenewal fee
03.05.1999Renewal fee patent year 03
02.05.2000Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]EP0344519  (BAYER AG [DE]) [A] 1-10* page 16, line 12; example 34; claim - *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.